Strategies for management of blood vessels on the surface of the eye

Phase 1

• Conditions: Corneal new vessels; Therapeutic area: Diseases [C] - Eye Diseases [C11]

• Registration Number: EUCTR2015-003180-11-GB
• Lead Sponsor: niversity of Nottingham

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-09
• Last Update Posted: 16 December 2019

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients with all the below criteria:
-Patients over the age of 18
-Able to give informed consent
-Use of effective contraception in females of childbearing age

-With corneal neovascularisation non responsive or not suitable for conventional steroid therapY

Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

-Patients under 18 years of age
-Patients unable or refusing to provide informed consent
-Patients who are needle phobic
-Pregnant women or women aiming for conception and breast feeding women.
-Patients with hypersensitivity to the active substance or to any of the excipients
-Patients with active or suspected ocular or periocular infections.
-Patients with active severe intraocular inflammation.
-Patients with raised intraocular pressure or on glaucoma medication

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified